David James Lennon's most recent trade in Whitehawk Therapeutics Inc. was a trade of 51,021 Common Stock done at an average price of $3.9 . Disclosure was reported to the exchange on May 14, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Whitehawk Therapeutics Inc | David James Lennon | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 3.92 per share. | 14 May 2026 | 51,021 | 569,643 | - | 3.9 | 200,002 | Common Stock |
| Whitehawk Therapeutics Inc | David James Lennon | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 3.38 per share. | 09 Apr 2026 | 14,500 | 518,622 | - | 3.4 | 49,010 | Common Stock |
| Whitehawk Therapeutics Inc | David James Lennon | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 3.51 per share. | 06 Apr 2026 | 102,395 | 691,154 | - | 3.5 | 359,406 | Common Stock |
| Whitehawk Therapeutics Inc | David James Lennon | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 3.43 per share. | 06 Apr 2026 | 94,087 | 597,067 | - | 3.4 | 322,718 | Common Stock |
| Whitehawk Therapeutics Inc | David James Lennon | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 3.40 per share. | 06 Apr 2026 | 63,945 | 533,122 | - | 3.4 | 217,413 | Common Stock |
| Whitehawk Therapeutics Inc | David James Lennon | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2026 | 831,148 | 831,148 | - | - | Stock Option (right to buy) | |
| Whitehawk Therapeutics Inc | David James Lennon | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2026 | 775,828 | 820,407 | - | - | Common Stock | |
| Whitehawk Therapeutics Inc | David James Lennon | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2026 | 775,828 | 0 | - | - | Restricted Stock Units | |
| Whitehawk Therapeutics Inc | David James Lennon | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 3.48 per share. | 01 Apr 2026 | 26,858 | 793,549 | - | 3.5 | 93,466 | Common Stock |
| Whitehawk Therapeutics Inc | David James Lennon | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2026 | 16,250 | 49,679 | - | - | Common Stock | |
| Whitehawk Therapeutics Inc | David James Lennon | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2026 | 16,250 | 32,500 | - | - | Restricted Stock Units | |
| Whitehawk Therapeutics Inc | David James Lennon | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 3.31 per share. | 01 Mar 2026 | 5,100 | 44,579 | - | 3.3 | 16,879 | Common Stock |
| Whitehawk Therapeutics Inc | David James Lennon | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2025 | 775,828 | 775,828 | - | - | Stock Option (right to buy) | |
| Whitehawk Therapeutics Inc | David James Lennon | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2025 | 775,828 | 775,828 | - | - | Restricted Stock Units | |
| Whitehawk Therapeutics Inc | David James Lennon | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2025 | 16,250 | 39,119 | - | - | Common Stock | |
| Whitehawk Therapeutics Inc | David James Lennon | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2025 | 16,250 | 48,750 | - | - | Restricted Stock Units | |
| Whitehawk Therapeutics Inc | David James Lennon | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 2.35 per share. | 01 Mar 2025 | 5,690 | 33,429 | - | 2.4 | 13,372 | Common Stock |
| Whitehawk Therapeutics Inc | David James Lennon | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Oct 2024 | 32,558 | 0 | - | - | Restricted Stock Units | |
| Whitehawk Therapeutics Inc | David James Lennon | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Oct 2024 | 32,558 | 32,558 | - | 0 | Common Stock | |
| Whitehawk Therapeutics Inc | David James Lennon | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 1.94 per share. | 02 Oct 2024 | 9,689 | 22,869 | - | 1.9 | 18,797 | Common Stock |
| Whitehawk Therapeutics Inc | David James Lennon | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 130,000 | 130,000 | - | - | Stock Option (right to buy) | |
| Whitehawk Therapeutics Inc | David James Lennon | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 65,000 | 65,000 | - | - | Restricted Stock Units | |
| Whitehawk Therapeutics Inc | David James Lennon | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 30,768 | 30,768 | - | - | Stock option (right to buy) |